Cell-Free DNA Can Improve GI Cancer DetectionFebruary 7th 2020
Cell-free DNA could be the next big breakthrough in detecting gastrointestinal cancers, according to Brian M. Wolpin, MD, MPH, director of the Gastrointestinal Cancer Center, and director of the Hale Family Center for Pancreatic Cancer Research at Dana-Farber Cancer.
Ovarian Suppression Plus AI Treatment Can Have Major Adverse EventsJanuary 25th 2020
Combining ovarian suppression and an aromatase inhibitor is an efficacious treatment method for premenopausal women with breast cancer. However, the regimen (which is given long-term) can cause some major adverse events, explained Dawn L. Hershman, MD, MS, professor of medicine and epidemiology at the Columbia University Irving Medical Center.
Nurses: Frequently Discuss AEs With Your PatientsJanuary 9th 2020
Frequent communication between patients and providers is key in getting ahead of adverse events that can occur during breast cancer treatment, explained Madeline Kuiper, MSN, RN, OCN, an oncology nurse practitioner at UCLA.
Utilizing Treatment Free Survival as an Endpoint in ResearchNovember 28th 2019
As immune checkpoint inhibitors begin to reshape how to treat patients with cancer, understanding treatment-free survival as an endpoint in clinical research can better characterize the effects of the treatment.